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Pathways of bacterial energy metabolism, such as
the protonmotive force (PMF), have largely remained
unexplored as drug targets, owing to toxicity con-
cerns. Here, we elaborate on a methodical and
systematic approach for targeting the PMF using
chemical combinations. We began with a high-
throughput screen to identify molecules that selec-
tively dissipate either component of the PMF, DJ
or DpH, in Staphylococcus aureus. We uncovered
six perturbants of PMF, three that countered DJ
and three that selectively dissipated DpH. Combina-
tions of dissipators of DJ with dissipators of DpH
were highly synergistic against methicillin-resistant
S. aureus. Cytotoxicity analyses on mammalian cells
revealed that the dose-sparing effect of the observed
synergies could significantly reduce toxicity. The
discovery and combination of modulators of DJ
and DpH may represent a promising strategy for
combating microbial pathogens.INTRODUCTION
Emergence and spread of multidrug-resistant bacteria repre-
sents an increasingly serious problem and an unmet medical
need due to the lack of therapeutic options. The situation is
especially dire for Staphylococcus aureus for which methicillin-
resistant S. aureus (MRSA) and vancomycin intermediate-resis-
tant S. aureus (VISA) strains have emerged (Chopra, 2003). The
escalating concern of antibiotic resistance coupled with the
dwindling antibiotic pipeline has prompted drug developers to
turn to unconventional strategies for the discovery of novel drugs
to combat bacterial infections, both in exploring novel com-
pound classes and validating new target pathways.
The cell membrane of S. aureus, in particular, is a relatively
unexplored target for the development of novel antimicrobials.
This essential macromolecular structure plays a critical role in
cellular activities such as active transport of substances into
the cell, cellular respiration, the establishment of the proton
motive force, and cell-cell communication (Hurdle et al., 2011).1168 Chemistry & Biology 20, 1168–1178, September 19, 2013 ª201Yet, over the years, discovery efforts have steered clear of mem-
brane-active agents that either disrupt the membrane’s physical
integrity or target its energetics, mostly given their propensity to
cause toxicity in mammals. In fact, a consensus has emerged in
the field that active compounds discovered in whole cells
screens that act primarily on the cell membrane should be
excluded from further study (O’Neill and Chopra, 2004; Silver,
2011). Indeed, a number of assays have been explored to detect
these undesirable compounds early enough to evade follow-up
studies (Gentry et al., 2010; Prakash Singh, 2006).
Paradoxically, this unconventional antibacterial target has
gained attention, in part because of studies showing its impor-
tance in nongrowing bacteria (Coates and Hu, 2008; Hu et al.,
2010; Hurdle et al., 2011) and out of recognition of the recent
success of the antibiotic medicines daptomycin (Hawkey,
2008), telavancin (Zhanel et al., 2010), and HT61 (Hu et al.,
2010), all of which work by permeablizing and depolarizing the
cytoplasmic membrane of S. aureus. Also noteworthy is the
compound TMC107, which disrupts membrane energetics by
targeting the ATP synthase and is currently in phase IIb trials
for the treatment of drug-resistant Mycobacterium tuberculosis
(Balemans et al., 2012). Nevertheless, the energetic pathways
of the bacterial membrane remain largely unexplored and rela-
tively unpopular drug targets.
In bacteria, the extrusion of protons by the electron transport
chain results in an electrochemical gradient of protons, known
as the proton motive force (PMF), generated across the cell
membrane. The PMF is subsequently necessary for ATP synthe-
sis by the F1F0-ATPase and for transport of various solutes
(Mitchell, 1966). The PMF is made up of the sum of two param-
eters: the electric potential (DJ) and the transmembrane proton
gradient (DpH). Critical to bacterial survival, the PMF has never-
theless been largely disregarded as a target for antimicrobials,
owing to toxicity concerns. Still, ionophores such as the natural
product monensin, that dissipate the PMF by disrupting the flow
of ions across the membrane, have found extensive use as anti-
bacterial agents in the cattle and poultry industries (Russell and
Houlihan, 2003). Interestingly, bacteria exercise exquisite control
over DJ and DpH in order to maintain a constant value of PMF.
Dissipation in either component is compensated for by a coun-
teracting increase in the other (Bakker and Mangerich, 1981).
In this work, we sought to exploit this compensation mechanism
as an Achilles heel in bacteria that would be exquisitely suscep-
tible to a combination of perturbants, one that specifically3 Elsevier Ltd All rights reserved
Figure 1. A High-Throughput Screen to
Identify Dissipaters of DJ and DpH
(A) Fluorescence of DiSC3(5) over time following
addition of DMSO (blue), valinomycin (5 mM),
which disrupts DJ (green), and nigericin (5 mM),
which disrupts DpH (red). DiSC3(5) dye was first
added at 10 s followed by self-quenching and
stabilization. Solvent or compounds were added
at 270 s.
(B) Replicate plot of the DiSC3(5) primary screen.
S. aureus was grown and loaded with DiSC3(5).
Cells were added to one of each of the 30,000
compounds at 10 mM. Shown are the normalized
ratios of fluorescence values of two replicate
samples. The cutoff score for molecules that
increased DiSC3(5) fluorescence was chosen as
R1.4 and for molecules that decreased fluo-
rescence %0.25. Active compounds are shown
in red.
(C) Schematic diagram of the work flow from the
high-throughput screen of 30,000 compounds to
yield the active compounds that increased fluo-
rescence, I1, I2, and I3 as well as those that
decreased fluorescence, D1, D2, and D3. Com-
pounds were eliminated at each stage according
to the criteria indicated. Specifically, after con-
firming a dose-dependent fluorescence response,
the various compounds were tested for the effect of pH on their activity and their ability to suppress the activity of the aminoglycoside (AG), kanamycin, and
tetracycline (TET). In aggregate, six compounds were confirmed as modulators of components of PMF. These were investigated for synergistic activity against
MRSA.
See also Figures S1–S3.
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Synergy by Collapsing the Proton Motive Forcedisrupted the electric potential (DJ) and another, the transmem-
brane proton gradient (DpH).
We set out to identify specific disrupters of the electrical and
chemical components of PMF through a fluorescence-based
high-throughput screen. In particular, the screen identified three
compounds that specifically dissipated DJ and three that selec-
tively disrupted DpH. We demonstrated profound synergy
between these two classes of compounds when used in combi-
nation against MRSA. Thus, the concerted dissipation ofDJ and
DpH had a synergistic effect in collapsing the PMF and, impor-
tantly, this synergy spares the doses that are necessary for
each of the individual agents. We show that this dose-sparing
phenomenon likewise reduces the toxicity of the respective
agents. Indeed, drug combination therapy is gaining favor (Keith
et al., 2005) because of increased efficacy, lower toxicity, and
reduced propensity for resistance (Cottarel and Wierzbowski,
2007). Here, we report on a systematic effort in discovering syn-
ergistic antibacterial chemical combinations that exploits the
interdependence of the electric potential and chemical gradient
of the membrane in maintaining the proton motive force. These
findings suggest new opportunities to target energetic systems
within bacterial pathogens as a means to develop novel thera-
peutic strategies.
RESULTS
Development of a High-Throughput Screen for
Alterations in PMF
A widely used probe to study the effect of small molecules on
membrane potential is the cationic, membrane potential-sensi-
tive dye, 3,30-dipropylthiacarbocyanine iodide [DiSC3(5)] (WuChemistry & Biology 20, 1168–117et al., 1999). In this fluorescence-based assay, bacteria are
grown and loaded with dye, which accumulates in the cyto-
plasmic membrane in response to DJ and self-quenches its
own fluorescence. When DJ is disrupted or the membrane per-
meabilized upon treatment with a small molecule, the dye is
released into the medium resulting in an increase in fluores-
cence. Interestingly, this dye can also inform on dissipation in
the other component of PMF, the transmembrane DpH, through
observed decreases in fluorescence. Upon dissipation of their
pH gradient, bacterial cells will compensate by increasing DJ
to maintain a constant PMF. As such, this increased membrane
potential further concentrates DiSC3(5) dye in the membrane,
such that high local concentrations lead to decreased fluores-
cence intensity due to further quenching. As validation for the
assay, we measured the effect of valinomycin (in the presence
of K+) and nigericin. Valinomcyin, a K+ ionophore which specif-
ically dissipates the DJ component of the PMF, led to a signifi-
cant increase in fluorescence (Figure 1A), whereas nigericin, an
electroneutral antiporter for H+ and K+, caused a decrease in
fluorescence as it selectively dissipates DpH (Figure 1A). Solvent
(DMSO)-treated DiSC3(5)-loaded cells did not lead to changes in
fluorescence consistent with an intact membrane potential (Fig-
ure 1A). Having established DiSC3(5) as a suitable tool to identify
molecules that selectively dissipate both components of the
PMF, we adapted the methodology to a microwell plate format
to allow screening of large numbers of compounds. In this assay,
after loading S. aureus cells with DiSC3(5) and treating with com-
pound, dissipation of either DJ or DpH was immediate, but
stable for at least 30 min, which allowed a sufficient window
of time for recording fluorescence intensity. Overall, the opti-
mized DiSC3(5) microwell assay had robust signal and noise8, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1169
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and 0.80, using known probes valinomycin and nigericin for in-
creases and decreases in fluorescence intensity, respectively.
We carried out a high-throughput screen (HTS) for DiSC3(5)
fluorescence using a diverse collection of synthetic chemicals
and known bioactive compounds (30,000 compounds) assayed
at 10 mM against S. aureus (strain Newman). Results of the
screen are shown in Figure 1B, plotted as a normalized fluores-
cence ratio (see Experimental Procedures) such that a ratio of
1.0 represents no change in fluorescence. We set stringent, arbi-
trary cutoffs for both increases and decreases in fluorescence as
ratios of 1.4 and 0.25, respectively. This translated to 79 com-
pounds that increased fluorescence and 272 compounds that
decreased fluorescence (Figure 1C). A counterscreen of the
active compounds was conducted to account for fluorescence
artifacts, which could arise from intrinsically fluorescent com-
pounds or compounds that quench DiSC3(5) fluorescence, inde-
pendent of the proton motive force (Figure S1 available online).
The latter effect, assessed by reading the fluorescence intensity
in the absence of cells but in the presence of dye, was a very
important counterscreen and reduced the number of active
compounds that decreased fluorescence to 29. The 79 active
compounds that increased DiSC3(5) fluorescence displayed no
fluorescence artifacts (Figure 1C).
Follow-Up to the HTS
In order to confirm active molecules from the HTS, we generated
dose response analyses using a range of compound concentra-
tions to assess the dose dependence of the fluorescence
readout. Of the 79 compounds that increased fluorescence in
the primary screen, 57 dissipated the membrane potential in a
concentration-dependent manner (Figure 1C). We eliminated
22 compounds whose effects on DiSC3(5) fluorescence did not
occur in a clear dose-dependent fashion or showed high
variability in fluorescence readings among three replicates
(examples in Figure S2A). Among the 29 compounds that
decreased fluorescence, 19 compounds confirmed as causing
a dose-dependent reduction in the pH gradient. Similarly, here,
we eliminated ten compounds that did not display clear dose-
dependence or exhibited high variability among the three repli-
cates (examples in Figure S2B). Subsequently, we narrowed
our list of molecules based on conventional filters, such as visual
inspection of chemical structures, ability to resupply, and growth
inhibitory potency (detailed process in Figure S3) against
S. aureus. Although not all dissipaters of components of the
PMF have antibacterial activity, we focused on molecules that
were inhibitory against S. aureus. Importantly, we also observed
that antibacterial activity of the molecules against S. aureus
correlated well with their ability to dissipate either DJ or DpH.
Overall, we narrowed our working set of molecules to ten com-
pounds, seven of which caused an increase in fluorescence
(‘‘I’’ molecules) and potential dissipaters of DJ and three
causing a decrease in dye fluorescence (‘‘D’’ molecules), poten-
tially dissipating DpH (Figure 1C).
Uncovering Agents that Selectively Dissipate
Components of PMF
The nature of the screen not only allows for the discovery of mol-
ecules that selectively dissipate components of the PMF, but1170 Chemistry & Biology 20, 1168–1178, September 19, 2013 ª201also agents that permeabilize the membrane allowing DiSC3(5)
dye to be released. Further, because PMF is generated by the
electron transport chain, inhibitors of this respiration process
may also be uncovered in the screen. It was therefore important
to further investigate the mode of action of the active com-
pounds to ensure selective disruption of components of the
PMF. To this end, we first assessed the impact of pH on the
activity of these compounds. Because the two components of
the PMF, the membrane potential and the transmembrane pH
gradient (the difference between the intracellular and extracel-
lular pH) are interdependent, a shift in the extracellular pH to
alkaline values leads to a decrease in the pH gradient across
the membrane, such that the compensatory component, DJ,
accounts for a greater share of the PMF (Booth, 1985). In
contrast, a shift to acidic values leads to an increase in DpH
across the membrane resulting in a compensatory fall in DJ,
such that DpH becomes the dominant component (Booth,
1985). A shift in pH to alkaline values led to potentiation of the
antibacterial activity of I1, I2, and I3 but did not enhance the
activity of the four remaining I molecules, suggesting the former
molecules selectively modulate DJ. The chemical structures of
I1, I2, and I3 are shown in Figure 2A along with their DiSC3(5)
dose-response curves in Figure 2B. Specifically, a range of pH
5.5 to pH 9.5 led to a 32-fold change in the minimum inhibitory
concentration (MIC) of molecule I1 (Figure 2Ci), a 64-fold shift
for I2 (Figure 2Cii), and a 16-fold change for I3 (Figure 2Ciii).
Conversely, the antibacterial activity of D1, D2, and D3, for which
chemical structures and dose-response curves are shown in Fig-
ure 3, increased as pH values became more acidic, consistent
with selective disruption of DpH. D1 exhibited a 16-fold change
in MIC (Figure 3Ci), whereas D2 and D3 showed a 32-fold (Fig-
ure 3Cii) and an 8-fold change in MIC (Figure 3Ciii) from a pH
range of 9.5 to 5.5, respectively. To further corroborate that the
effects of I1-I3 and D1–D3 are specific to components of PMF,
we tested their interactions with the aminoglycoside antibiotic
kanamycin, whose uptake is driven by DJ (Taber et al., 1987),
and with tetracycline, whose uptake is specifically driven by
DpH (Yamaguchi et al., 1991). Indeed, molecules I1–I3 antago-
nized the activity of kanamycin consistent with the hypothesis
that these compounds perturb DJ. Further, D1–D3 suppressed
the activity of tetracycline against S. aureus supporting the
conclusion that these molecules act on DpH (Table S1). As
confirmation for the interplay between DJ and DpH, those mol-
ecules that potentiated aminoglycoside activity clearly also sup-
pressed tetracycline action and vice-versa (Table S2).
Thus molecules I1–I3 and D1–D3 represented strong candi-
date perturbants of DJ and DpH, where the ultimate goal
was testing their efficacy in combination against S. aureus.
Regarding the remaining molecules, I4–I7, that showed no pH
dependency and did not show signature antagonism with kana-
mycin, we posited that these likely disrupted membrane struc-
ture or inhibited other aspects of bacterial respiration. Indeed,
we tested these hypotheses as described below.
Characterizing I1, I2, and I3, Potential Dissipaters ofDJ
To further characterize the action of I1, I2, and I3, the potential
modulators of DJ, we first assessed their impact on the ener-
getic condition of S. aureus cells by measuring their effect on
the reduction of iodonitrotetrazolium chloride (INT). INT, a3 Elsevier Ltd All rights reserved
Figure 2. Hit Compounds I1, I2, and I3 Dissipate DJ of S. aureus
(A) Chemical structures of (i) I1 (logP = 4.02), (ii) I2 (logP = 2.65), and (iii) I3 (logP = 1.56).
(B) Concentration-dependent effect of (i) I1, (ii) I2, and (iii) I3 on DiSC3(5) fluorescence. All three compounds caused a dose-dependent increase in fluorescence,
indicative of dissipation of DJ. Error bars represent the SEM of three replicates.
(C) The effect of altering the external pH on the minimum inhibitory concentration of (i) I1, (ii) I2, and (iii) I3 is shown. The growth inhibitory activity of all three
compounds is enhanced in when the external pH is shifted to an alkaline environment, where DJ becomes the main component of PMF.
See also Tables S1 and S2.
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by components of the prokaryotic respiratory chain (Altman,
1976). Because PMF and the ETC are closely interlinked,
whereby generation of an electrochemical proton gradient
occurs as a result of the extrusion of protons by the electron
transport chain, we reasoned that dissipation of this gradient
across the cytoplasmic membrane should ultimately affect elec-
tron transport across the respiratory chain. Overall, when tested
at concentrations equivalent to their MICs, all three molecules
led to significant decreases in the reduction of INT to its forma-
zan product as compared to the untreated control, suggesting
that the electron transport across the cytoplasmic membrane
was impaired (Figure 4A).
We next investigated the extent to which I1, I2, and I3, by dissi-
pating the membrane potential, interfere with respiratory ATP
production. The proton motive force is essential for the produc-
tion of ATP via the F0F1-ATPase, such that dissipation of this
electrochemical gradient should halt ATP production. Intracel-
lular ATP levels were measured by a luciferin-luciferase biolumi-
nescence assay at the MIC values of the various compounds. As
depicted in Figure 4B, upon addition of I1, intracellular ATP levels
drastically decreased by 84% compared to DMSO-treated
control. Similarly, I2 decreased ATP levels by 41%, whereasChemistry & Biology 20, 1168–117I3 decreased ATP levels by 81% compared to the control. This
is consistent with amode of action of dissipatingDJ; upon treat-
ment with the various molecules, the intracellular ATP pool is
depleted in an attempt to maintain the PMF. These results also
suggest that interference with ATP synthesis or depletion of
the cellular ATP poolmay be the cause of bacterial killing of these
molecules as single agents.
We further assessed whether treatment with I1, I2, and I3
results in the efflux of cell constituents by measuring for any
loss of materials absorbing at 260 nm. Leakage of cellular con-
stituents, such as potassium ions, amino acids, and ATP, is a
commonmechanism shared bymany small molecules that dissi-
pate PMF. Although some cause pores (Garcera´ et al., 1993;
McAuliffe et al., 1998), others integrate in the membrane (Silver-
man et al., 2003; Ultee et al., 1999), similar to an ionophore-like
inhibitor and cause dissipation of the ion gradients. In this assay,
molecules I2 and I3 did not cause a leak of cellular constituents,
as compared to the DMSO control (Figure 4C). Nisin, a pore-
forming lantibiotic (Garcera´ et al., 1993), served as a positive
control and led to a significant increase in absorbance, con-
sistent with its mode of action. I1 caused an intermediate absor-
bance at a concentration equivalent to its MIC (Figure 4C).
This increased absorbance is likely attributable to I1’s high8, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1171
Figure 3. Hit Molecules D1, D2, and D3 Dissipate DpH of S. aureus
(A) Chemical structures of (i) D1 (logP = 2.33), (ii) D2 (logP = 2.72), and (iii) D3 (logP = 3.02).
(B) Concentration-dependent effect of (i) D1, (ii) D2, and (iii) D3 on DiSC3(5) fluorescence. All three compounds caused a dose-dependent decrease in fluo-
rescence, indicative of dissipation of DpH. Error bars represent the SEM of three replicates.
(C) The effect of altering the external pH on the minimum inhibitory concentration of (i) D1, (ii) D2, and (iii) D3 is shown. The growth inhibitory activity of all three
compounds is enhanced in when the external pH is shifted to an acidic environment, where DpH becomes the main component of PMF.
See also Tables S1 and S2.
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plasmic membrane, consequently dissipating the transmem-
brane ion gradient. Nucleic acids, which were leaked through a
damaged cytoplasmic membrane, were more abundant with
increased concentrations of I1 (data not shown), presumably
as more I1 dissolves into the membrane. It should be noted
that, at the pertinent tested concentration, there was no
decrease in the optical density of the I1-treated cell suspensions,
indicating that cell lysis did not occur. The same can be said of
treatment with I2 and I3. Thus, we suggest that the collapse of
DJ at the concentrations tested was caused by compound-
mediated effects on the cell membrane rather than having
occurred as a result of general cell lysis. Although I1, I2, and I3
all act on the membrane, only I1was disruptive to its structural
integrity, causing leakage of large nucleotides, whereas I2 and
I3 likely only cause small ions to be transported or released
across its surface. Overall, molecules I1, I2, and I3 all decreased
membrane potential, which in turn inhibited ATP production and
depleted energy in the cell, leading to reduced viability.
Characterizing D1, D2, and D3, Potential Dissipaters of
DpH
Similar to molecules I1–I3, we first assessed the effect of mole-
cules D1, D2, and D3 on the reduction of INT (Figure 5A). All three1172 Chemistry & Biology 20, 1168–1178, September 19, 2013 ª201molecules had adverse effects on cellular respiration,
decreasing the production of formazan product, consistent
with an action of dissipating PMF.
Additionally, D1, D2, and D3 also depleted cellular energy
stores by causing a decrease in intracellular levels of ATP, how-
ever, to a lesser extent than I molecules. Becausemembrane po-
tential, but not the pH gradient, is essential for the synthesis of
ATP by the F1F0-ATPase (Kaim and Dimroth, 1998), it is not sur-
prising that D1, D2, and D3 only decreased ATP levels by 37%,
16%, and 46%, respectively (Figure 5B). Finally, none of the dis-
sipaters of DpH caused a significant leakage of cell constituents
when tested at MIC values (Figure 5C), suggesting that they do
not cause damage to the physical integrity of the membrane.
Characterizing I4, I5, I6, and I7: Other Molecules that
Caused an Increase in DiSC3(5) Fluorescence
A number of molecules were uncovered in the HTS causing an
increase in DiSC3(5) fluorescence but whose activity was not
suppressed by an acidic external pH. We suspected that such
molecules might inhibit cellular respiration, ultimately affecting
membrane potential, or simply disrupt the membrane, allowing
DiSC3(5) dye to be released.
Molecule I4 (Figure S4A) caused a dose-dependent increase
in DiSC3(5) fluorescence (Figure S4B), but its activity was not3 Elsevier Ltd All rights reserved
Figure 4. Effect of Potential Dissipaters of DJ at MIC Concentrations on Cellular Respiration, ATP Levels, and Membrane Integrity
(A) Effects of I1, I2, and I3 on the reduction of INT to its formazan product, which can be detected at an absorbance of 490 nm. Error bars represent the SEM of
three replicates.
(B) Effects of compounds on intracellular ATP levels, measured by a luciferin-luciferase bioluminescence assay. Values are relative to DMSO control. Error bars
represent the SEM of three replicates.
(C) Measure of leakage of cellular constituents at 260 nm with nisin as a positive control. Error bars represent the SEM of three replicates.
The MIC concentration of I1 is 8 mg/ml, I2 is 2 mg/ml, and I3 is 2 mg/ml.
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did, however, suppress the activity of kanamycin against
S. aureus by 8-fold (data not show), suggesting that I4may inhibit
cellular respiration. In fact, aminoglycoside bacterial uptake not
only requires intact DJ, but also electron flow through the mem-
brane-associated respiratory chain (Taber et al., 1987). Expect-
edly, I4 led to decreased INT reduction as well as decreased
intracellular ATP levels, as intact cellular respiration is required
for both (Figures S4C and S4D). We also assessed its potential
membrane-damaging properties by measuring for any loss of
260 nm absorbing material. I4 did not cause any significant
release of cell constituents, suggesting it does not inhibit growth
by permeabilizing the membrane of S. aureus (data not shown).
Finally, cells treated with I4 had a significant reduction in their
amount of staphyloxanthin pigment compared to untreated cells
(Figure S4E). Staphyloxanthin synthesis has been shown to
require intact cellular respiration (von Eiff et al., 2006). I4 may
be driving S. aureus into fermentative growth, which would
explain the decrease in ATP yield. Additionally, because pyru-
vate is shunted to support fermentation, less acetyl-CoA would
enter the mevalonate pathway necessary for staphyloxanthin
synthesis (Pelz et al., 2005). Interestingly, I4 synergized with
I1–I3 and D1–D3 (Table S3), molecules that inhibit the generation
of PMF, lending further support to the notion that I4 targets
cellular respiration as a mechanism of action. In combination
with these molecules, we would expect a respiration inhibitor
to further deplete energy reserves leading to reduced viability.
Other active compounds, I5, I6, and I7 (Figure S5A) induced
similar effects on S. aureus. All three caused significant
increases in DiSC3 fluorescence (Figure S5B). Unlike our specific
dissipaters of DJ, their antibacterial activities were not potenti-
ated upon a pH shift to alkaline values, and they enhanced the
activity of the kanamycin, instead of suppressing it. All threemol-
ecules did, however, cause a gross leakage of UV-absorbing
material (Figure S5C), similar to nisin, suggesting that they may
lead to structural disruption of themembrane. This permeabiliza-
tion is likely the cause of the increase in DiSC3(5) dye, which isChemistry & Biology 20, 1168–117released in the medium and may also explain the observed
enhanced activity of kanamycin, whose uptake would be
accordingly facilitated. Interestingly, molecule I7 was structurally
a bile salt, compounds known to disrupt cellular membranes
(Ross et al., 2004). By disrupting membrane integrity, I5, I6,
and I7 expectedly caused decreases in INT reduction and ATP
levels (Table S4), as the respiratory chain and metabolic path-
ways within the cytoplasmic membrane would be destroyed.
Further, the membrane damage caused by I5, I6, and I7 could
be large enough to allow the leakage of large compounds,
such as ATP. Finally, all three compounds were also synergistic
with I1–I3 and D1–D3, the selective dissipaters of DJ and DpH,
again likely due to their facilitated uptake into the cell and likely
unrelated to an energetic mechanism.
Combinations of Molecules I1–I3 and D1–D3 Lead to
Synergistic Interactions
Our overriding objective for the discovery of molecules that
selectively dissipate DJ and DpH was their combination. We
hypothesized that combining antibacterial compounds be-
longing to these two mechanistic classes would circumvent
the compensatory responses in DJ and DpH that maintain
PMF. Accordingly, we predicted synergistic, dose-sparing inter-
actions from such combinations. We performed all possible
combinations among molecules I1–I3 and molecules D1–D3
using antibacterial checkerboard methodology (White et al.,
1996) against the highly problematic community-acquired meth-
icillin-resistant strain of S. aureus, USA 300 (CA-MRSA USA300)
(Figure 6). Here, we define synergy as having an FIC index of%
0.5, additivity as 1–2, and antagonism asR2. In all cases, syn-
ergy was observed with FIC indices%0.5. The most potent syn-
ergies were observed for combinations of I2 with D2 and I3 with
D3, each resulting in an FIC index of 0.25 (Figure 6). As controls,
we also performed all combinations among the I molecules and
on the other hand, among the D molecules; all combinations led
to FIC indices ranging between 0.75–2 (data not shown), indica-
tive of additive interactions.8, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1173
Figure 5. Effect of Potential Dissipaters of DpH at MIC Values on Cellular Respiration, ATP Levels, and Membrane Integrity
(A) Effects of D1, D2m andD3 on the reduction of INT to its formazan product, which can be detected at an absorbance of 490 nm. Error bars represent the SEMof
three replicates.
(B) Effects of compounds on intracellular ATP levels, measured by a luciferin-luciferase bioluminescence assay. Values are relative to DMSO control. Error bars
represent the SEM of three replicates.
(C) Measure of leakage of cellular constituents at 260 nm. Here, nisin is a positive control. Error bars represent the SEM of three replicates.
The MIC concentration of D1 is 32 mg/ml, D2 is 8 mg/ml, and D3 is 128 mg/ml.
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The cytotoxic effects of compounds I1–I3 and D1–D3 against
HeLa cells were evaluated by quantifying the release lactate
dehydrogenase (LDH) upon cellular necrosis (Nachlas et al.,
1960) (Figure 7A). In this assay, only two compounds, I1 and
D1, significantly reduced cell viability by 41% and 47% at their
antibacterial MIC values of 8 mg/ml and 32 mg/ml, respectively.
At MIC concentrations, compounds I2 (MIC 2–4 mg/ml) and I3
(MIC 2–4 mg/ml) reduced cell viability by 9% and 6%, whereas
D2 (MIC 8 mg/ml) andD3 (MIC 128 mg/ml) by 2%and 5%, respec-
tively. Beyond the MIC values of the compounds, however, all
but D3 showed significant cytotoxic effects on HeLa cells.
We next assessed whether toxicity at concentrations that lead
to synergistic interactions could be minimized compared to
toxicity of the compounds as antibacterial agents alone (Fig-
ure 7B). Overall, it was evident that the observed synergistic
combinations would allow for reduced doses to be used, indeed
minimizing cytotoxicity. We tested three of the nine combina-
tions, I1 + D1, I2 + D2, and I3 + D3, at the concentration of
each molecule that led to synergy for cytotoxicity effects (Fig-
ure 7B). Overall, toxicity of each compound could be reduced
in combination, thus allowing for dose-sparing effects. For
example, molecule I1 (that causes 41% toxicity alone) when
combinedwith D1 (47% toxicity alone) at their effective synergis-
tic concentrations led to 19% toxicity (Figure 7B). In combina-
tion, the activity of I1 is potentiated 4-fold by D1, reducing its
cytotoxicity at that concentration to <25%, whereas D1 is poten-
tiated 8-fold by I1, reducing its toxicity by over 20%. In other
cases, such as with I2 and D2, displaying 9% and 2% cytotox-
icity as single agents, respectively, resulted in very minimal cyto-
toxicity in combination (5%) (Figure 7B). Finally, as a single
agent, I3 exhibited 10% toxicity at its MIC concentration and
D3, 5% cytotoxicity. In combination, however, the total cytotox-
icity at their effective synergistic concentrations was 7%, thus
remaining almost negligible (Figure 7B). Overall, whereas all six
compounds exhibited some moderate cytotoxicity, their combi-
nations to achieve enhanced antibacterial efficacy allowed the
ability to reduce cytotoxicity effects.1174 Chemistry & Biology 20, 1168–1178, September 19, 2013 ª201DISCUSSION
Bacteria establish and maintain an electrochemical gradient of
protons across their cytoplasmic membrane, known as the
PMF (Mitchell, 1966). This PMF is essential for a variety of critical
bacterial processes, such as ATP synthesis, flagellar motility,
and nutrient import. Collapse of the PMF inhibits these important
functions and thus results in the loss of bacterial viability. A
unique feature of the PMF is its composition of two components
that continually work together to maintain homeostasis (Bakker
and Mangerich, 1981). Dissipation of one component of the
gradient is buffered by a counteracting increase in the other in
order to maintain a constant value for the PMF. Nevertheless,
most modern antibacterial discovery efforts purposely depriori-
tize molecules that disrupt membrane energetics. In the work
reported here, we explore the potential of combining small mol-
ecules that perturb the DJ and DpH components of the PMF,
with the underlying hypothesis that such agents should show ad-
vantageous synergy in combination.
Having established DiSC3(5) fluorescence as a robust assay to
identify dissipaters of DJ and DpH, we screened a chemical
library for small molecules modulators of DJ and DpH. Com-
pounds specific to DJ and DpH were subsequently identified
by their ability to suppress the activity of aminoglycosides or tet-
racyclines. Such molecules could also be modulated with
changes in the external pH. This effort resulted in the identifica-
tion of molecules I1, I2, and I3, which dissipate membrane
potential, and D1, D2, and D3, which dissipate the pH gradient
across the cell membrane of S. aureus. As expected, I1–I3 and
D1–D3 all reduced the pool of intracellular ATP. We also uncov-
ered a potential inhibitor of respiration, I4, as well as three mem-
brane-damaging agents, I5, I6, and I7, which all led to increases
in DiSC3(5) fluorescence.
Interestingly, Oyamada et al. (2006) have previously reported
on molecule I1, discovered in an anucleate cell blue assay per-
formed to identify type II topoisomerase inhibitors against
Escherichia coli. In their in vitro follow-up, however, we note
that I1 exhibited a very high IC50 toward purified gyrase and3 Elsevier Ltd All rights reserved
Figure 6. Combinations of Dissipaters of DJ and DpH Exhibit Synergistic Interactions
Microdilution checkerboard analyses show all possible combined effects of molecules I1–I3 with molecules D1–D3 against CA-MRSA USA300 where the
extent of inhibition is shown as a heat plot. In all cases, synergistic effects are evident and result in the following FIC indices: I1-D1 0.37, I1-D2 0.5, I1-D3 0.37, I2-
D1 0.5, I2-D2 0.25, I2-D3 0.5, I3-D1 0.37, I3-D2 0.5, and I3-D3 0.25. FIC Index was calculated by the sum of the FIC of each compound, calculated as such; FIC =
[X]/MICX, where [X] is the lowest inhibitory concentration of drug in the presence of the codrug.
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Synergy by Collapsing the Proton Motive Forcetopoisomerase IV, namely 50 mg/ml (171 mM) and >100 mg/ml
(>342 mM), respectively. Further, molecule I3 is a natural product,
known as agelasine found in marine sponges (Agelas sp.).
Notably, no previous characterization of its antibacterial activity
has been reported, but it has been characterized as a putative in-
hibitor of human Na/K-ATPase (Trachtenberg et al., 1981).
Importantly, in combination, synergistic interactions among
our dissipaters of DJ and dissipaters of DpH were observed
and proved efficacious against MRSA. One advantage afforded
by combination therapy over monotherapies is the ability to
circumvent toxicity with dose-sparing concentrations of two-
component therapy. Indeed, in the work presented here, cyto-
toxicity was significantly reduced through reductions in dose
that were made possible by the synergies of I and D molecules
when used in combination.Chemistry & Biology 20, 1168–117Although molecules that act on the membrane are often
associated with toxicities, it is nevertheless clear that bacterial
specificity is, in fact, attainable. The success stories of antibac-
terials such as daptomycin and telavancin, which depolarize the
cytoplasmic membrane, reinforce the point that selective
toxicity is achievable (Hurdle et al., 2011). In our case, mole-
cules I1–I3 and D1–D3 displayed relatively low cytotoxicity at
pertinent concentrations (i.e., those relating to antibacterial
activity). Only I1 and D1 displayed high cytotoxicity against
HeLa cells at very high concentrations, in many cases well
above 32-fold their antibacterial inhibitory activity. Importantly,
however, cytotoxicity was often negligible at MIC concentra-
tions. In eukaryotic cells, the respiratory chain and resulting
PMF is in the mitochondrial membrane instead of the cyto-
plasmic membrane. This distinct localization of the respiratory8, September 19, 2013 ª2013 Elsevier Ltd All rights reserved 1175
Figure 7. Cytotoxic Effects of Compounds
I1, I2, and I3 as well as D1, D2, and D3 and
Their Combinations on a HeLa Cell Line
(A) Cytotoxic effects of compounds I1–I3 and D1–
D3 following exposure to different concentrations
of compounds. Cell viability was assessed using
LDH release method. All values are relative to the
maximum LDH release control. Effect by the sol-
vent DMSO was subtracted. Error bars represent
the SEM of three replicates.
(B) Cytotoxic effects of individual compounds at
MIC (antibacterial) concentrations and at concen-
trations that are effective (antibacterial) when used
in the synergistic combinations indicated. Error
bars represent the SEM of three replicates.
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Synergy by Collapsing the Proton Motive Forcechain between eukaryotic and bacterial cells could partly
explain the observed low toxicity (Wu et al., 2010). Neverthe-
less, their combinations allowed for dose-sparing effects and
further lowered cytotoxicities.
A number of molecules impart bactericidal activity by
collapsing the PMF, including a variety of antimicrobial peptides
(Peters et al., 2010; Wilmes et al., 2011), which do so by forming
pores and uncoupling agents that inhibit oxidative phosphoryla-
tion (Terada, 1990); fewer, however, selectively dissipate either
component of the PMF (McAuliffe et al., 1998). Discriminating
between decreases in the individual components of the PMF
allows for a greater control of bacterial membrane energetics
and gives an opportunity for collapsing the PMF via chemical
combinations. In fact, targeting redundancy and homeostasis
is a critical feature of combinatorial therapy and at the root of
successful combination therapies (Cottarel and Wierzbowski,
2007; Fitzgerald et al., 2006).
We speculate that collapsing the PMF might be ideal as an
antibacterial strategy against a variety of species. Compounds
that collapse the PMF inhibit flagellar motility (Paul et al.,
2008), preventing invasion (Nan et al., 2011) and swarming
activities that eventually lead to biofilm formation (Ikonomidis
et al., 2008). The PMF also plays a necessary role in protein
excretion and the export of many toxic-secreted metabolites
(Geller, 1991), which could be prevented by perturbing the
PMF. Additionally, PMF-targeted molecules and their combina-
tions could be expected to inhibit more efficiently dormant
bacteria, a subpopulation of slow-growing or nongrowing
microorganisms that play important roles in many persistent
infections (Lewis, 2007). Dormant bacteria already have a
reduced cellular metabolism, with a lowered but adequate pro-
ton motive force (Hurdle et al., 2011) and could thus be more
susceptible to modulators of the PMF. Finally, many antibiotic
efflux pumps are driven by the PMF (Paulsen et al., 1996),
thus dissipaters of PMF could find utility as novel adjuvants to
conventional antibiotics.
In the work reported here, we have presented a proof of
concept for a rational and methodical strategy for the discovery
of chemical combinations that block PMF in a synergistic
manner. This method of achieving efficacy, although minimizing
potential toxicities by targeting two interlinked components of a
common pathway, provides a foundation for subsequent devel-
opment of highly potent combinations and for the application to
other compensatory pathways in the cell.1176 Chemistry & Biology 20, 1168–1178, September 19, 2013 ª201SIGNIFICANCE
Recently, we have seen a groundswell of concern over the
lack of effective antibiotics to treat bacterial infection. The
growing number of multidrug-resistant pathogens coupled
with the retreat of the pharmaceutical sector from new anti-
biotic development has exacerbated this problem such that
new, perhaps unconventional strategies are needed to meet
these health challenges. Here, we report on an innovative
approach to uncover synergistic combinations effective
against resistant pathogens such as methicillin-resistant
Staphylococcus aureus. Using a fluorescence-based high-
throughput screen of S. aureus, we have identified selective
dissipaters of either DJ or DpH, the components that make
up the proton motive force (PMF). We reasoned that combi-
nations of selective DJ and DpH perturbants would be
uniquely synergistic because of a requirement in bacteria
to maintain a constant PMF across the cytoplasmic mem-
brane by balancing both components. We have identified
three dissipaters of DJ and three dissipaters of DpH and
provided evidence that strategically modulating DJ and
DpH in concert via combinations leads to profound synergy
with potent activity against MRSA. Additionally, we have
shown that the synergy among these membrane-active
compounds allows for considerable dose-sparing and as a
result, lower toxicity. Indeed, modern antibacterial drug
discovery has largely avoided membrane-active agents
because of toxicity challenges. This work represents an
alternative approach to tackle infectious pathogens and
provides a methodical strategy to uncover synergistic anti-
bacterial drug combinations.EXPERIMENTAL PROCEDURES
Materials and Bacterial Strains
3,30-Dipropylthiacarbocyanine iodide and all antibiotics used in the study were
purchased from Sigma Aldrich. The strains used in the study are S. aureus
(strain Newman strain) and CA-MRSA USA 300. Mueller Hinton Broth was
used as the growth medium.
High-Throughput Screening for Molecules that Modulate PMF of
S. aureus
Effects of compounds on the bioenergetics of the cytoplasmic membrane of
S. aureus (strain Newman) were determined using the membrane potential-
sensitive cyanine dye DiSC3(5) by a modification of the method of Epand3 Elsevier Ltd All rights reserved
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washed three times, and resuspended in a buffer containing 10mMpotassium
phosphate, 5 mM MgSO4, and 250 mM sucrose (pH 7.0). After the final wash,
pellets were resuspended in the same buffer to an optical density (OD)600 of
0.085. The cells were loadedwith 1 mMDiSC3(5) and allowed to stabilize before
adding to assay plates containing compounds. Compounds were dispensed
into 96-well assay plates (final concentration of 10 mM) using a Biomek FX
liquid handler (Beckman Coulter). Cells were added using a mfill system (Bio-
tek). Fluorescence was monitored at one time point using an EnVision plate
reader (Perkin Elmer) at an excitation wavelength of 620 nm and an emission
wavelength of 685 nm. The screen was completed in duplicate and each assay
plate contained controls (16 wells total) including background DMSO controls,
valinomycin, and nigericin controls. All raw data points were normalized to the
mean of the middle two quartiles computed on an individual plate basis, to
account for plate-to-plate variation, resulting in a ratio, where a high ratio indi-
cates dissipation of DJ and a low ratio, dissipation of DpH. Positive and nega-
tive controls on each plate were used as checkpoints that the assay was
running correctly. Hit compounds were selected based on an arbitrary cut-
off of 1.4 for molecules that caused an increase in fluorescence and 0.25 for
molecules that caused a decrease in fluorescence.
Counter Screen for Fluorescence Artifacts
Fluorescence artifacts were accounted for by measuring the fluorescence of
the compounds that caused an increase in fluorescence on their own in assay
buffer relative to DMSO controls. Conversely, compounds that caused a
decrease in fluorescence were screened for their ability to quench the fluores-
cence of DiSC3(5) in assay buffer in the absence of cells.
Dose-Response Studies
Half-log serial dilutions of the hit compounds were prepared and aliquoted into
assay plates. Fluorescence values were obtained in a similar manner as the
screen. Curves were plotted on GraFit; any molecules with deviations from a
clear dose-response relationship were eliminated.
MIC Determinations
Protocol for MIC determinations was based on Clinical and Laboratory Stan-
dards Institute (CLSI) guidelines. Plates were incubated at 37C for 18 hr
and optical density read at 600 nm. The MIC for the drug was the lowest con-
centration showing <10% growth.
INT Reduction Assay
S. aureus cells were grown from an overnight culture to exponential phase and
washed and resuspended in 0.1 M potassium phosphate buffer (pH 7.5) to an
optical density of 0.3 and kept on ice. In glass tubes, compound was added in
buffer with 1 mM INT and 1 ml of cell in a total volume of 3 ml. Tubes were
mixed vigorously and absorbance at 490 nm was read at 10 min intervals.
Tubes were incubated at 30C between reads.
ATP Levels
Protocol was adapted from Patton et al. (2006). ATP concentrations were
determined using an ATP bioluminescent assay kit (Sigma) according to
the manufacturer’s instructions. Bioluminescence was measured using an
EnVision plate reader (Perkin-Elmer).
Staphyloxanthin Levels
S. aureus cell culture at an OD 0.1 was treated with compound and grown at
37C for 24 hr. Cells were centrifuged and pellets washed twice with PBS.
Pigment was extracted in methanol, placing the samples in a 40C water
bath for 20 min. Samples were cooled and the absorbance of the extracted
staphyloxanthin pigment was read at 450 nm and normalized to OD at
600 nm of the initial culture.
Checkerboard Analyses and FIC Index Determination
FICs were determined by setting up standard checkerboard broth microdilu-
tion assays using the conditions based on CLSI guidelines. Each drug was
serially diluted at eight different concentrations to create an 8 3 8 matrix. At
least three replicates were done for each combination and the means used
for calculation. The FIC for each drug was calculated as the concentration ofChemistry & Biology 20, 1168–117drug in the presence of codrug in a combination for a well showing <10%
growth, divided by the MIC for that drug. The FIC index is the sum of the
two FICs. Chemical-chemical interactions with an FIC index %0.5 were
deemed synergistic.
Cytotoxicity Assays
Cytotoxicity experiments were performed using the CytoTox 96 nonradioac-
tive cytotoxicity assay (Promega), which measures the release of lactate dehy-
drogenase (LDH) upon cellular necrosis. Briefly, HeLa cells were seeded at 104
cells per well of a 96-well plate in DMEM supplemented with 10% fetal calf
serum and 1% Pen-Strep and incubated for 24–26 hr at 37C/5% CO2.
Upon reaching 90%–95% confluence, cells were washed and stimulated
with each compound in duplicate or triplicate at a concentration of 1 in 100
in complete DMEM. After 18 hr, LDH release wasmeasured according to man-
ufacturer’s instructions. Each experiment was performed in triplicate, and all
values are presented as relative to the maximum LDH release control,
achieved by incubating unstimulated cells with 13 lysis buffer for 45 min prior
to the measurement of LDH release.
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